Year: 2008
Type: editorial
Abstract: S ince the initial proof of concept that catheter ablation could prevent recurrent atrial fibrillation (AF), there has been a considerable evolution in the focus of studies to evaluate this therapy.Initial studies were typically single center and aimed at ablation of paroxysmal AF in healthy young patients, with a relatively superficial end point of absence of recurrent symptomatic AF (ie, monitoring was minimal) in short term follow up.Technique was emphasized, with each group trumpeting the superiority of the lesion strategy of the day.Through this experience, procedural complications have decreased and attention has been directed gradually to patients with more-established AF.Guidelines have been developed 1,2 to attempt to enforce more uniform descriptions of complications and success, with a focus on extensive monitoring for asymptomatic recurrence.
Source: Circulation
Author: David J. Callans
Institution: University of Pennsylvania
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2167620341